342
Views
9
CrossRef citations to date
0
Altmetric
Original Article

Estimate of maintenance EPO to darbepoetin alfa dose conversion ratio in a hospital-based dialysis patient population

, , , &
Pages 2679-2687 | Accepted 14 Sep 2010, Published online: 13 Oct 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Holger Schmid. (2014) Cost-effectiveness of continuous erythropoietin receptor activator in anemia. ClinicoEconomics and Outcomes Research 6, pages 319-330.
Read now

Articles from other publishers (8)

Hyo Jin Kim, Ji In Park, Kyung Don Yoo, Yunmi Kim, Hyunjeong Baek, Sung Ho Kim, Taehoon Chang, Hye Hyeon Kim, Kye Hwa Lee, Seungsik Hwang, Clara Tammy Kim, Hoseok Koo & Ju Han Kim. (2020) Real-world treatment patterns of renal anemia in hemodialysis patients. Medicine 99:2, pages e18749.
Crossref
Hung-Chieh Yeh, Yu-Ting Lin, I-Wen Ting, Han-Chun Huang, Hsiu-Yin Chiang, Chih-Wei Chung, Shih-Ni Chang & Chin-Chi Kuo. (2019) Variability of red blood cell size predicts all-cause mortality, but not progression to dialysis, in patients with chronic kidney disease: A 13-year pre-ESRD registry-based cohort. Clinica Chimica Acta 497, pages 163-171.
Crossref
Andrea L. Woodland, Sean W. Murphy, Bryan M. Curtis & Brendan J. Barrett. (2017) Costs Associated With Intravenous Darbepoetin Versus Epoetin Therapy in Hemodialysis Patients: A Randomized Controlled Trial. Canadian Journal of Kidney Health and Disease 4, pages 205435811771646.
Crossref
Paweena Susantitaphong, Fahad Alqahtani & Bertrand L. Jaber. (2014) Efficacy and Safety of Intravenous Iron Therapy for Functional Iron Deficiency Anemia in Hemodialysis Patients: A Meta-Analysis. American Journal of Nephrology 39:2, pages 130-141.
Crossref
Paweena Susantitaphong, Cristian Riella & Bertrand L. Jaber. (2013) Effect of ultrapure dialysate on markers of inflammation, oxidative stress, nutrition and anemia parameters: a meta-analysis. Nephrology Dialysis Transplantation 28:2, pages 438-446.
Crossref
Walter H. Hörl. (2013) Differentiating Factors Between Erythropoiesis-Stimulating Agents: An Update to Selection for Anaemia of Chronic Kidney Disease. Drugs 73:2, pages 117-130.
Crossref
Ioannis Koulouridis, Mansour Alfayez, Thomas A. Trikalinos, Ethan M. Balk & Bertrand L. Jaber. (2013) Dose of Erythropoiesis-Stimulating Agents and Adverse Outcomes in CKD: A Metaregression Analysis. American Journal of Kidney Diseases 61:1, pages 44-56.
Crossref
R. Binaut, J.-L. Bacri, D. Fleury, N. Maisonneuve, D. Labatut, V. Lemaître, Z. Medeghri & G. Bir. (2012) Conversion de l’époétine alfa à la darbépoétine alfa chez des patients insuffisants rénaux chroniques hémodialysés : observatoire monocentrique (Valenciennes). Néphrologie & Thérapeutique 8:5, pages 326.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.